Premier Anti-Aging Co., Ltd. (4934) AI Stock Analysis

• Market Cap: ¥6.31B
• Dividend Yield: N/A
• Average Volume (3M): 28.94K
• Price to Earnings (P/E): 13.4
• Beta (1Y): 1.07
• Revenue Growth: -20.62%
• EPS Growth: N/A
• Country: JP
• Employees: 229
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): -33.39
• Shares Outstanding: 8,720,534
• 10 Day Avg. Volume: 18,190
• 30 Day Avg. Volume: 28,936
• PEG Ratio: -0.12
• Price to Book (P/B): 1.14
• Price to Sales (P/S): 0.47
• P/FCF Ratio: 5.22
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 52 Neutral
• Price Target: ¥743.00 ▲(6.45% Upside)

The overall stock score is primarily impacted by the company's financial performance, which shows strengths in gross profit margin and balance sheet stability but is hindered by declining revenues and low profitability. Technical analysis indicates bearish momentum, further weighing down the score. Valuation is a relative strength, with a reasonable P/E ratio, but the lack of a dividend yield is a drawback.

Premier Anti-Aging Co., Ltd. Business Overview & Revenue Model

Company Description

Premier Anti-Aging Co., Ltd. (4934) is a leading company in the health and beauty sector, specializing in the development and distribution of innovative anti-aging products. The company focuses on harnessing advanced biotechnology and research to create skincare solutions that promote youthful appearance and skin health. Its core product offerings include a range of serums, creams, and supplements designed to combat signs of aging, catering to a diverse customer base seeking effective and high-quality beauty products.

How the Company Makes Money

Premier Anti-Aging Co., Ltd. generates revenue primarily through the sale of its anti-aging skincare products and dietary supplements. The company employs a multi-channel distribution strategy, selling its products through e-commerce platforms, retail partnerships with beauty stores, and direct-to-consumer channels. Key revenue streams include online sales, wholesale partnerships with beauty retailers, and subscription services for regular customers. Additionally, the company may engage in strategic partnerships with dermatologists and beauty influencers to enhance its market presence and drive product visibility, contributing significantly to its earnings.

Premier Anti-Aging Co., Ltd. Financial Statement Overview

Summary

Premier Anti-Aging Co., Ltd. shows a strong gross profit margin and a stable balance sheet with low leverage. However, declining revenues and low net profit margins are concerning. Cash flow has improved, but operational efficiency needs enhancement to boost profitability.

Income Statement

Premier Anti-Aging Co., Ltd. has experienced declining revenue over the past few years, with a negative revenue growth rate of -7.23% in the most recent year. The gross profit margin remains strong at 76.65%, indicating efficient production processes. However, the net profit margin is low at 2.91%, reflecting challenges in controlling costs or increasing sales. The EBIT and EBITDA margins are also low, suggesting limited operational efficiency and profitability.

Balance Sheet

The company's balance sheet shows a stable debt-to-equity ratio of 0.17, indicating conservative leverage. The return on equity is moderate at 7.13%, suggesting reasonable profitability from shareholders' investments. The equity ratio is healthy, reflecting a solid capital structure with a good proportion of equity financing.

Cash Flow

Cash flow analysis reveals a significant improvement in free cash flow, with a growth rate of 'Infinity' due to a previous negative base. The operating cash flow to net income ratio is 0.49, indicating moderate cash generation relative to net income. The free cash flow to net income ratio is high at 0.98, suggesting effective conversion of profits into cash.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	16.16B	16.16B	20.36B	26.40B	33.91B	32.81B
Gross Profit	12.39B	12.39B	16.10B	19.24B	26.63B	26.43B
EBITDA	876.00M	916.00M	-627.00M	-432.24M	2.67B	4.71B
Net Income	471.00M	471.00M	-1.48B	-733.97M	1.42B	2.79B
Balance Sheet
Total Assets	10.14B	10.14B	11.00B	12.14B	12.30B	13.07B
Cash, Cash Equivalents and Short-Term Investments	4.66B	4.66B	4.76B	4.67B	2.97B	6.06B
Total Debt	1.11B	1.11B	2.44B	2.26B	1.41B	911.41M
Total Liabilities	3.53B	3.53B	4.88B	4.53B	3.95B	6.17B
Stockholders Equity	6.61B	6.61B	6.12B	7.61B	8.35B	6.90B
Cash Flow
Free Cash Flow	0.00	1.44B	-395.00M	1.64B	-3.53B	2.68B
Operating Cash Flow	0.00	1.47B	425.00M	2.42B	-3.32B	2.75B
Investing Cash Flow	0.00	-229.00M	-540.00M	-900.97M	-297.68M	-180.83M
Financing Cash Flow	0.00	-1.34B	183.00M	179.77M	501.62M	1.58B

Premier Anti-Aging Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 698.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4934, the sentiment is Negative. The current price of 698 is below the 20-day moving average (MA) of 736.55, below the 50-day MA of 822.50, and below the 200-day MA of 849.18, indicating a bearish trend. The MACD of -32.88 indicates Negative momentum. The RSI at 38.05 is Neutral, neither overbought nor oversold. The STOCH value of 78.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4934.

Premier Anti-Aging Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4936	67 Neutral	¥10.80B	29.52	―	2.21%	10.56%	-52.16%
4925	63 Neutral	¥6.30B	9.84	―	2.40%	-3.27%	―
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
4929	60 Neutral	¥6.07B	157.92	―	1.58%	-9.99%	-35.06%
4934	52 Neutral	¥6.31B	13.37	―	―	-20.62%	―
4935	49 Neutral	¥11.23B	―	―	0.47%	9.74%	-669.35%
4926	45 Neutral	¥5.12B	20.35	―	1.67%	7.21%	―

Premier Anti-Aging Co., Ltd. Corporate Events

Premier Anti-Aging Revises Earnings Forecast Amid Mixed Business Performance

Premier Anti-Aging Co., Ltd. has revised its full-year consolidated earnings forecast for the fiscal year ending July 31, 2025, due to mixed performance across its business segments. While the recovery business through subsidiary Venex Co., Ltd. showed strong sales, the anti-aging segment underperformed, leading to an overall reduction in expected net sales. Despite this, operating profit exceeded expectations due to reduced advertising expenses and effective cost management. The company plans to invest in marketing for its renewed ‘DUO’ brand and new ‘Lalaskin’ skincare line, while remaining cautious about the challenging business environment, particularly in the Chinese market.

Premier Anti-Aging Reports Financial Results and Revises Forecasts

Premier Anti-Aging Co., Ltd. reported a decrease in net sales and operating profits for the first nine months of the fiscal year ending July 31, 2025, compared to the previous year. Despite the decline in sales, the company achieved a profit attributable to owners of the parent, indicating a recovery from the previous year’s losses. The company has revised its earnings forecasts for the full fiscal year, suggesting a cautious yet optimistic outlook for future performance.